A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT.

Matt Kaeberlein, the CEO of Optispan, shared his longevity habits.Matt KaeberleinMatt Kaeberlein, a longevity researcher and CEO of Optispan, had symptoms of low testosterone.He got his levels tested in his 50s and gradually began testosterone replacement therapy (TRT).He said...

🔗 Read more: https://www.businessinsider.com/longevity-researcher-tips-starting-testosterone-replacement-therapy-what-to-know-2026-2

#News #Health #Biology #Tech #Business #Medicine